Page last updated: 2024-08-23

valrubicin and Carcinoma, Epidermoid

valrubicin has been researched along with Carcinoma, Epidermoid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, SM; Dagnaes-Hansen, F; Dam, TN; de Darkó, E; Laugesen, IG; Rosada, C; Stenderup, K1
Ahmed, A; Hengesteg, A; Israel, M; Koseki, Y; Robbins, KT; Samant, S; Sweatman, TW; Wani, MK; Yarber, RH1

Other Studies

2 other study(ies) available for valrubicin and Carcinoma, Epidermoid

ArticleYear
Topical application of valrubicin has a beneficial effect on developing skin tumors.
    Carcinogenesis, 2010, Volume: 31, Issue:8

    Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Apoptosis; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Cells, Cultured; Doxorubicin; Humans; Keratinocytes; Keratosis, Actinic; Mice; Papilloma; Skin; Skin Neoplasms

2010
Rationale for intralesional valrubicin in chemoradiation of squamous cell carcinoma of the head and neck.
    The Laryngoscope, 2000, Volume: 110, Issue:12

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Cricetinae; Doxorubicin; Head and Neck Neoplasms; Injections, Intralesional; Models, Animal; Tumor Cells, Cultured

2000